Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Total 13F shares
-
1,976,740
-
Share change
-
+41,351
-
Total reported value
-
$133,000
-
Price per share
-
$0.0652
-
Number of holders
-
12
-
Value change
-
+$3,680
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q3 2022
As of 30 Sep 2022 Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) had 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,976,740 shares of stock of the company.
Largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, Ionic Capital Management LLC, Owl Creek Asset Management, L.P., TENOR CAPITAL MANAGEMENT Co., L.P., Privium Fund Management B.V., ZAZOVE ASSOCIATES LLC, Shaolin Capital Management LLC, EQUITEC PROPRIETARY MARKETS, LLC, COWEN AND COMPANY, LLC, and HRT FINANCIAL LP.
This table shows 12 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.